Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force, an influential panel of experts who assess ...

The FDA approved a new gene therapy for Sanfilippo syndrome type A, an ultra-rare disease sometimes known as childhood ...

Amid a civil war in Sudan, it’s now difficult for people with cancer and other long-term illnesses to receive treatment that ...

Why a biotech hedge fund decided to build from the ground up a new company to develop a better, long-acting antibody ...

Cautious optimism in the Ebola outbreak, FDA still stymied by DOGE cuts, and other health updates from the Morning Rounds ...

It wasn’t until he started medical school, Brian Zhang writes, that he realized ‘Asian glow’ from drinking was a sign of ...

International researchers got a reprieve in the courts this week. What does that mean for U.S. medical research? Find out on ...

FDA's hiring bottleneck, Dems plan for health care oversight, and more from STAT's D.C. Diagnosis newsletter.

For all the talk of a hiring spree at the FDA after DOGE cuts last year, the reality is more complicated and filled with ...

Researchers have identified a very rare genetic variant that is associated with higher odds of lung cancer in "never smokers." ...

Health secretary RFK Jr. returned to his roots in a keynote address at a conference hosted by the Children’s Health Defense, an anti-vaccine nonprofit he helped start.

Sellas Life Sciences Group is a blowup waiting to happen. My prediction: Sellas’ experimental immunotherapy will fail to prolong survival compared to standard treatment for patients with acute myeloid ...